Nutex Health, Inc. (NUTX)
USD 134.23
(-7.45%)
USD 134.23
(-7.45%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 247.64 Million USD | 12.93% |
| 2022 | 219.29 Million USD | -33.85% |
| 2021 | 331.53 Million USD | 21.25% |
| 2020 | 273.42 Million USD | 181.71% |
| 2019 | 97.05 Million USD | 106120.79% |
| 2018 | 91.37 Thousand USD | 70.32% |
| 2017 | 53.64 Thousand USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2011 | 2.54 Million USD | 101.26% |
| 2010 | 1.26 Million USD | 474.39% |
| 2009 | 220.46 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 67.45 Million USD | -3.18% |
| 2024 Q2 | 76.08 Million USD | 12.79% |
| 2023 Q4 | 69.66 Million USD | 11.07% |
| 2023 Q1 | 56.32 Million USD | 4.85% |
| 2023 Q2 | 58.92 Million USD | 4.61% |
| 2023 Q3 | 62.72 Million USD | 6.45% |
| 2023 FY | 247.64 Million USD | 12.93% |
| 2022 Q2 | 58.04 Million USD | 834.87% |
| 2022 Q3 | 28.39 Million USD | -51.08% |
| 2022 FY | 219.29 Million USD | -33.85% |
| 2022 Q1 | 6.2 Million USD | -90.45% |
| 2022 Q4 | 53.72 Million USD | 89.2% |
| 2021 FY | 331.53 Million USD | 21.25% |
| 2021 Q2 | 62.81 Million USD | 3018.37% |
| 2021 Q4 | 65.02 Million USD | -44.88% |
| 2021 Q3 | 117.97 Million USD | 87.81% |
| 2021 Q1 | 2.01 Million USD | -98.1% |
| 2020 Q2 | 643.44 Thousand USD | -3.21% |
| 2020 Q4 | 106.13 Million USD | 18821.12% |
| 2020 FY | 273.42 Million USD | 181.71% |
| 2020 Q1 | 664.75 Thousand USD | -69.1% |
| 2020 Q3 | 560.92 Thousand USD | -12.82% |
| 2019 Q4 | 2.15 Million USD | 12129.14% |
| 2019 FY | 97.05 Million USD | 106120.79% |
| 2019 Q1 | 13.53 Thousand USD | -63.64% |
| 2019 Q3 | 17.59 Thousand USD | 22.28% |
| 2019 Q2 | 14.38 Thousand USD | 6.32% |
| 2018 Q1 | 12.12 Thousand USD | 102.04% |
| 2018 Q4 | 37.21 Thousand USD | 22.35% |
| 2018 FY | 91.37 Thousand USD | 70.32% |
| 2018 Q3 | 30.41 Thousand USD | 161.76% |
| 2018 Q2 | 11.62 Thousand USD | -4.14% |
| 2017 Q2 | 19.02 Thousand USD | 0.0% |
| 2017 Q3 | 26.96 Thousand USD | 41.71% |
| 2017 FY | 53.64 Thousand USD | 0.0% |
| 2017 Q4 | -593.65 Thousand USD | -2301.67% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2011 Q4 | 706.18 Thousand USD | 17.44% |
| 2011 Q1 | 542.12 Thousand USD | 9.93% |
| 2011 Q2 | 699.03 Thousand USD | 28.94% |
| 2011 Q3 | 601.31 Thousand USD | -13.98% |
| 2011 FY | 2.54 Million USD | 101.26% |
| 2010 FY | 1.26 Million USD | 474.39% |
| 2010 Q4 | 493.16 Thousand USD | 129.15% |
| 2010 Q3 | 215.21 Thousand USD | -37.21% |
| 2010 Q1 | 215.21 Thousand USD | 0.0% |
| 2010 Q2 | 342.77 Thousand USD | 59.27% |
| 2009 FY | 220.46 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| iCoreConnect Inc. | 8.15 Million USD | -2938.014% |
| Accolade, Inc. | 414.29 Million USD | 40.224% |
| Augmedix, Inc. | 44.85 Million USD | -452.104% |
| BrightSpring Health Services, Inc. Common Stock | 8.82 Billion USD | 97.194% |
| CareCloud, Inc. | 117.05 Million USD | -111.557% |
| CareCloud, Inc. | 117.05 Million USD | -111.557% |
| Definitive Healthcare Corp. | 251.41 Million USD | 1.499% |
| Health Catalyst, Inc. | 295.93 Million USD | 16.318% |
| HealthEquity, Inc. | 999.58 Million USD | 75.225% |
| HealthStream, Inc. | 279.06 Million USD | 11.258% |
| Inovalon Holdings, Inc. | 667.52 Million USD | 62.901% |
| Omnicell, Inc. | 1.14 Billion USD | 78.411% |
| OneMedNet Corporation | 1.02 Million USD | -24139.815% |
| Progyny, Inc. | 1.08 Billion USD | 77.251% |
| Renalytix Plc | 2.28 Million USD | -10718.974% |
| Schrödinger, Inc. | 216.66 Million USD | -14.299% |
| Simulations Plus, Inc. | 70.01 Million USD | -253.715% |
| Streamline Health Solutions, Inc. | 22.59 Million USD | -995.974% |
| SOPHiA GENETICS SA | 62.37 Million USD | -297.054% |
| Ontrak, Inc. | 12.74 Million USD | -1843.391% |
| Minerva Surgical, Inc. | 50.29 Million USD | -392.397% |
| GE HealthCare Technologies Inc. | 19.55 Billion USD | 98.733% |
| Sharecare, Inc. | 445.25 Million USD | 44.381% |
| Aclarion, Inc. | 75.4 Thousand USD | -328325.967% |
| CareMax, Inc. | 751.1 Million USD | 67.029% |
| Bullfrog AI Holdings, Inc. Common Stock | 65 Thousand USD | -380894.332% |
| Forian Inc. | 20.48 Million USD | -1109.132% |
| Bullfrog AI Holdings, Inc. Warrants | 65 Thousand USD | -380894.332% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 202.56 Million USD | -22.255% |
| SCWorx Corp. | 3.8 Million USD | -6408.542% |
| 10x Genomics, Inc. | 618.72 Million USD | 59.975% |
| Zhongchao Inc. | 19.43 Million USD | -1174.298% |
| MSP Recovery, Inc. | 7.7 Million USD | -3114.099% |
| R1 RCM Inc. | 2.25 Billion USD | 89.014% |
| Spok Holdings, Inc. | 139.02 Million USD | -78.131% |
| Privia Health Group, Inc. | 1.65 Billion USD | 85.061% |
| EUDA Health Holdings Limited | 3.7 Million USD | -6581.482% |
| TruBridge, Inc. | 339.43 Million USD | 27.042% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 8.82 Billion USD | 97.194% |
| Sharecare, Inc. | 445.25 Million USD | 44.381% |
| GoodRx Holdings, Inc. | 750.26 Million USD | 66.992% |
| Premier, Inc. | 1.34 Billion USD | 81.606% |
| Certara, Inc. | 354.33 Million USD | 30.11% |
| GeneDx Holdings Corp. | 202.56 Million USD | -22.255% |
| Ontrak, Inc. | 12.74 Million USD | -1843.391% |
| SHL Telemedicine Ltd. | 57.07 Million USD | -333.896% |
| CareCloud, Inc. | 117.05 Million USD | -111.557% |
| EUDA Health Holdings Limited | 3.7 Million USD | -6581.482% |
| HeartBeam, Inc. | - USD | -Infinity% |
| Mangoceuticals, Inc. | 731.49 Thousand USD | -33754.913% |
| CareMax, Inc. | 751.1 Million USD | 67.029% |
| Healthcare Triangle, Inc. | 33.2 Million USD | -645.855% |
| National Research Corporation | 148.58 Million USD | -66.675% |
| Aclarion, Inc. | 75.4 Thousand USD | -328325.967% |
| OptimizeRx Corporation | 71.52 Million USD | -246.254% |